Delivery Order SPE2DB22D3301-SPE2DB25FY1UL
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,699.90 to AmerisourceBergen Drug Corp for the supply of Chlorothiazide Sodium 500 mg vials. This non-set-aside, competitively awarded delivery order was issued on September 11, 2025, with an ultimate completion date of September 12, 2025. The contract utilizes firm fixed pricing and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a major pharmaceutical distributor and...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Chlorothiazide Sodium 500 mg vials under a firm fixed-price contract valued at $19,694.00. The award was issued on September 22, 2025, with an ultimate completion date of September 23, 2025. This delivery order was competitively awarded with no set-aside designation and represents a direct fulfillment of pharmaceutical supply needs for federal medical procurement. AmerisourceBergen Drug...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Chlorothiazide Sodium 500 mg vials, a medication used to treat high blood pressure and fluid retention. The delivery order, valued at $4,837.80, has a firm fixed price and an ultimate completion date of February 4, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) that...
- The Defense Logistics Agency awarded a delivery order valued at $6,178.70 to AmerisourceBergen Drug Corp for the supply of Chlorothiazide Sodium 500 mg vials. This non-set-aside, competitively awarded contract utilizing firm fixed pricing is scheduled for completion by July 15, 2025, with performance to take place at the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a continuation of AmerisourceBergen's extensive pharmaceutical supply...
- This is a firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the delivery of 500 mg vials of the medication Chlorothiazide Sodium, with a total ceiling value of $1,081.14 and a completion date of June 26, 2025. This contract is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA...
- The Defense Logistics Agency awarded a delivery order valued at $13,400.56 to AmerisourceBergen Drug Corp for the supply of Chlorothiazide Sodium 500 mg vials, with an ultimate completion date of September 23, 2025. This competitive award, issued on September 22, 2025, utilizes a firm fixed-price contract type with no set-aside designation. The award is issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive...
- The Defense Logistics Agency awarded a delivery order contract to AmerisourceBergen Drug Corp for the supply of Chlorothiazide Sodium 500 mg vials, with a ceiling value of $11,019.75 and a firm fixed price structure. The contract was competitively awarded without set-aside designation and is scheduled for completion by September 15, 2025. AmerisourceBergen will perform the work at its corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under the company's...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the supply of 500 mg vials of the pharmaceutical drug chlorothiazide sodium, with a ceiling value of $3,399.80 and a completion date of May 6, 2024. The award is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2025....
- This federal contract award is for the delivery of 4,564,556,909 units of Chlorothiazide Sodium 500 mg vials to the Defense Logistics Agency (DLA) Troop Support Medical. The contract was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc., for a ceiling value of $6,065.91. The contract is a delivery order with a firm fixed price pricing type and has a completion date of May 10, 2024. The contract is not designated with any set-aside requirements, indicating...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the supply of Chlorothiazide Sodium 500 mg vials, a pharmaceutical product, with a firm fixed price of $1,446.65 and a completion date of December 21, 2023. Amerisourcebergen Drug Corp is a for-profit organization that provides pharmaceutical products and services to U.S. government agencies, primarily the Department of Defense....
- SPE2DB22D3301Indefinite Delivery Contract
- SPE2DB22D3301-SPE2DB25FY1ULDelivery Order
This delivery order awards AmerisourceBergen Drug Corp $5,670.70 for the supply of Chlorothiazide Sodium 500 mg vials under a firm fixed-price contract with the Defense Logistics Agency (DLA). The contract was competitively awarded without a set-aside designation and carries an ultimate completion date of March 19, 2025. Performance will take place at the vendor's corporate office in Conshohocken, Pennsylvania. Chlorothiazide is a thiazide diuretic medication commonly used in military and federal healthcare systems for the treatment of hypertension and edema, making it a critical pharmaceutical commodity within the federal medical supply chain. This delivery order is a child contract issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The parent IDC serves as a comprehensive pharmaceutical support vehicle enabling the company to supply a broad range of medications, vaccines, and medical supplies to support military healthcare programs globally, including customers such as the Defense Health Agency and U.S. Coast Guard. AmerisourceBergen's role as a prime vendor reflects its position as a major pharmaceutical distributor providing critical medical commodities across multiple therapeutic domains to federal defense and healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.7k | 3/18/25 |